Literature DB >> 28683658

Estimating incidence and prevalence from population registers: example from myocardial infarction.

Karin Modig1, Anita Berglund1, Mats Talbäck1, Rickard Ljung1, Anders Ahlbom1,2.   

Abstract

AIM: To illustrate how the fundamental epidemiological measures, incidence rate and prevalence proportion, can be estimated based on Swedish population registers using acute myocardial infarction (MI) as an example, together with a discussion about the analytical decisions.
METHODS: All individuals in Sweden aged 60-89 (born 1904-1954) during the study period 1994-2014 were identified through the Total Population Register. Cases of MI were defined and identified from information on hospital admissions and causes of death. Incidence rates of all, first, and recurrent MI were calculated together with prevalence proportions.
RESULTS: The incidence rate of all, first, and recurrent MI declined over the study period. While the incidence rates of first MI are lower for women than men, the incidence rates of recurrent MI are considerably higher but similar for men and women. The prevalence calculated with duration of disease set at 28 days also declined. This was despite improved survival from MI and increased life expectancy over the same period meaning that the decline in incidence was large enough to compensate for increased survival.
CONCLUSIONS: Calculating incidence and prevalence of diseases using population registers requires detailed and well-reasoned definitions. The definitions will affect both the study population and the number of disease events and it is essential that the cases and the study population are defined in a coherent way. Different measures of disease occurrence contribute with different aspects of the disease panorama and a joint interpretation contributes to a thorough understanding of the disease development in a population.

Entities:  

Keywords:  Epidemiology; cardiovascular diseases; cause of death; epidemiologic measurements; incidence; population at risk; population registers; prevalence; recurrence

Mesh:

Year:  2017        PMID: 28683658     DOI: 10.1177/1403494817702327

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  6 in total

1.  The incidence and mortality of childhood acute lymphoblastic leukemia in Indonesia: A systematic review and meta-analysis.

Authors:  Dina Garniasih; Susi Susanah; Yunia Sribudiani; Dany Hilmanto
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

2.  Prevalence of left ventricular systolic dysfunction and heart failure with reduced ejection fraction in men and women with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Selma Bouthoorn; Aisha Gohar; Gideon Valstar; Hester M den Ruijter; J B Reitsma; Arno W Hoes; Frans H Rutten
Journal:  Cardiovasc Diabetol       Date:  2018-04-18       Impact factor: 9.951

3.  Incidence of gastrointestinal stromal tumor in Chinese urban population: A national population-based study.

Authors:  Lu Xu; Yanpeng Ma; Shengfeng Wang; Jingnan Feng; Lili Liu; Jinxi Wang; Guozhen Liu; Dianrong Xiu; Wei Fu; Siyan Zhan; Tao Sun; Pei Gao
Journal:  Cancer Med       Date:  2020-12-15       Impact factor: 4.452

4.  Gender differences in time to first hospital admission at age 60 in Denmark, 1995-2014.

Authors:  Andreas Höhn; Anna Oksuzyan; Rune Lindahl-Jacobsen; Kaare Christensen; Rosie Seaman
Journal:  Eur J Ageing       Date:  2021-03-27

5.  Do men avoid seeking medical advice? A register-based analysis of gender-specific changes in primary healthcare use after first hospitalisation at ages 60+ in Denmark.

Authors:  Andreas Höhn; Jutta Gampe; Rune Lindahl-Jacobsen; Kaare Christensen; Anna Oksuyzan
Journal:  J Epidemiol Community Health       Date:  2020-04-17       Impact factor: 3.710

6.  Rethinking morbidity compression.

Authors:  Rosie Seaman; Andreas Höhn; Rune Lindahl-Jacobsen; Pekka Martikainen; Alyson van Raalte; Kaare Christensen
Journal:  Eur J Epidemiol       Date:  2020-05-16       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.